Actuate Therapeutics Inc (ACTU) financial statements and ratios from SEC XBRL: revenue $287710.00 (TTM), net margin -7725.8%, revenue growth 29.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $287710.00 |
| Net Margin | -7725.8% |
| Revenue Growth (YoY) | 29.4% |
| EPS Growth (YoY) | -67.5% |
| Price / Book | 32.90 |
| Price / Sales | 113.96 |
| Altman Z-Score | -16.85 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ACTU overview · ACTU earnings · ACTU KPIs · ACTU investor relations · ACTU ownership · ACTU peers · ACTU filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.